Insulin-mediated growth in aortic smooth muscle and the vascular renin- angiotensin system

Hypertension

Volumn 32, Issue 3, 1998, Pages 482-487

  Kamide, Kei ^a   Hori, Mark T ^a   Zhu, Jian Hua ^a   Barrett, Jack D ^a   Eggena, Peter ^a   Tuck, Michael L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Angiotensinogen; Insulin; Muscle, smooth, vascular

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; CAPTOPRIL; INSULIN; LOSARTAN; MESSENGER RNA; MONOCLONAL ANTIBODY; RENIN; SOMATOMEDIN C RECEPTOR; THYMIDINE; TRITIUM;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HYPERTROPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

EID: 0031656260     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.3.482     Document Type: Article

References (53)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988; 37:1595-1606.
2. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglycemia, and hypertension. Arch Intern Med. 1989;149:1514-1520.
3. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaced syndrome for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
4. Kamide K, Nagano M, Nakano N, Kobayashi R, Yo Y, Rakugi H, Higaki J, Ogihara T. Insulin resistance and cardiovascular complications in patients with essential hypertension. Am J Hypertens. 1996;9:1165-1171.
5. Despres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
6. Kamide K, Rakugi H, Nakano N, Ohishi M, Nakata Y, Takami S, Katsuya T, Higaki J, Ogihara T. Insulin resistance is related to silent cerebral infarction in patients with essential hypertension. Am J Hypertens. 1997;10:1245-1249.
7. Tuck ML, Corry DB, Trujillo A. Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am J Med. 1990;88:210-216.
8. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and sympathoadrenal system. N Engl J Med. 1996;334:374-381.
9. Baron AD. Insulin and the vasculature: old actors, new roles. J Investig Med. 1996;44:406-412.
10. Saito F, Hori MT, Fittingoff M, Tuck ML. Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells. J Clin Invest. 1993;92:1158-1167.
11. Stout RW. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med. 1991;90:62S-65S.
12. Banskota NK, Taub R, Zellner K, Olsen P, King GL. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes. 1989;38:123-129.
13. Haffner SM, Mykkanen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR. Relationship of proinsulin and insulin to cardiovascular risk factors in non-diabetic subjects. Diabetes. 1993;42:1297-1302.
14. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991;324:1098-1104.
15. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989;321:868-873.
16. Iimura O, Shimamoto K, Matsuda K, Masuda A, Takizawa H. Higashiura K, Miyazaki Y, Hirata A, Ura N, Nakagawa M. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. Am J Hypertens. 1995;8:353-357.
17. Jost-Vu E, Horton R, Antonipillai I. Altered regulation of renin secretion by insulinlike growth factors and angiotensin II in diabetic rats. Diabetes. 1992;41:1100-1105.
18. Chobanian AV, Handenschield CC, Nickerson D, Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 1990;15:327-331.
19. Ambrosioni E, Bacchelli S, Esposti DD, Borghi C. ACE-inhibitors and experimental atherosclerosis. Clin Exp Hypertens. 1993;15:157-172.
20. Sugano M, Makino N, Yanaga T. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits. Atherosclerosis. 1996;127:123-129.
21. Zanchetti A. Antiatherosclerotic effects of antihypertensive drugs: recent evidence and ongoing trials. Clin Exp Hypertens. 1996;18:489-499.
22. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation. 1988;77(suppl I):I-4-I-13.
23. Eggena P, Barrett JD. The vascular renin system. In: Sowers JR, ed. Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:205-214.
24. Ross R. The smooth muscle cell: growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol. 1971;50:172-186.
25. Makita S, Nakamura M, Yoshida H, Hiramori K. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells. Life Sci. 1995;56:383-388.
26. Ikeda U, Shimada K. Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors. Eur J Pharmacol. 1994;269:319-323.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
28. Ohkubo H, Kageyama R, Ujiharan M, Hirose T, Inayama S, Nakanishi S. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci U S A. 1983;80:2196-2200.
29. Eggena P, Willesey P, Jamgotchian N, Truckenbrod L, Hu MS, Barrett JD, Eggena MP, Clegg K, Nakoul F, Lee DBN. The influence of recombinant human erythropoietin on blood pressure and tissue renin angiotensin systems of the rat. Am J Physiol. 1991;261:E642-E646.
30. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991;351:230-233.
31. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
32. Eggena P, Krall F, Eggena MP, Clegg K, Fittingoff M, Barrett JD. Production of angiotensinogen by cultured rat aortic smooth muscle cells. Clin Exp Hypertens. 1990;A12:1175-1189.
33. Eggena P, Barrett JD, Wiedeman CE, Sambhi MP. The validity of comparing the measurements of angiotensin I generated in human plasma by radioimmunoassay and bioassay. J Clin Endocrinol Metab. 1974;39:865-870.
34. Barrett JD, Eggena P, Sambhi MP. Influence of angiotensinase inhibitors on the enzymatic activity of renin. Biochem Med. 1976;16:157-168.
35. Barrett JD, Eggena P, Sowers JR, Sambhi MP. Effects of stimulation of renin release on trypsin activable renin in rat plasma. Am J Physiol. 1982;243:E206-E211.
36. Kasai K, Hori MT, Goodman WG. Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells. Endocrinology. 1990;126:1742-1749.
37. Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system. Hypertension. 1997;29:1014-1019.
38. Kobayashi R, Nagano M, Nakamura F, Higaki J, Fujioka Y, Ikegami H, Mikami H, Kawaguchi N, Onishi S, Ogihara T. Role of angiotensin II in high fructose- induced left ventricular hypertrophy in rats. Hypertension. 1993;21:1051-1055.
39. Iyer SN, Raizada MK, Katovich MJ. AT1 receptor density changes during development of hypertension in hyperinsulinemic rats. Clin Exp Hypertens. 1996;18:793-810.
40. Berk BC, Duff JL, Marrero MB, Bernstein KE. Angiotensin II signal transduction in vascular smooth muscle. In: Sowers JR, ed. Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:187-204.
41. Chen S, Kashiwabara H, Kosegawa I, Ishii J, Katayama S. Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor. Clin Exp Hypertens. 1996;18:625-636.
42. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest. 1994;93:339-346.
43. Chang E, Perlman AJ. Angiotensinogen mRNA: regulation by cell cycle and growth factors. J Biol Chem. 1988;263:5480-5484.
44. Ohtani R, Yayama K, Takano M, Itoh N, Okamoto H. Stimulation of angiotensinogen production in primary cultures of rat hepatocytes by glucocorticoid, cyclic adenosine 3′,5′-monophosphate, and interleukin-6. Endocrinology. 1992;130:1331-1338.
45. Pfeifle B, Ditschuneit H. Two separate receptors for insulin and insulin-like growth factors on arterial smooth muscle cells. Exp Clin Endocrinol. 1983;81:280-286.
46. King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science. 1985;227:1583-1585.
47. Steil GM, Ander M, Moore DM, Rebrin K, Bergman RN. Transendothelial insulin transport is not saturable in vivo: no evidence for a receptor-mediated process. J Clin Invest. 1996;97:1497-1503.
48. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Sequential changes in serum insulin concentration during development of non-insulin dependent diabetes. Lancet. 1989;1:1356-1359.
49. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension. 1995;26:869-879.
50. Delafontaine P, Lou H. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. J Biol Chem. 1993; 268:16866-16870.
51. O'Brien RM, Granner DK. Gene regulation. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus: A Fundamental and Clinical Text. 1st ed. Philadelphia, Pa: Lippincott-Raven; 1996:234-242.
52. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
53. Eggena P, Zhu JH, Clegg K, Barrett JD. Nuclear angiotensin receptors induce transcription of renin and angiotensin mRNA. Hypertension. 1993;22:496-501.